Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 2/2011

01.04.2011 | Original Article

Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time

verfasst von: Charlotte Dawson, Elaine Murphy, Charlé Maritz, Heidi Chan, Charlotte Ellerton, R. H. S. Carpenter, Robin H. Lachmann

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

There is no evidence that high phenylalanine (Phe) levels have irreversible effects on the adult brain. Many adults with phenylketonuria (PKU) no longer follow a protein-restricted diet. Neuropsychological studies have shown that reaction time in adults with PKU is slower than controls. There are no data to show that this is directly related to Phe levels. Another way to assess reaction time is to measure saccadic latency. We have used a portable, head-mounted saccadometer to measure latency in the outpatient setting. Patients with PKU were split into three groups: off-diet (Phe>1,200 μmol/l), on-diet (Phe <800 μmol/l) and maternal diet (Phe 100–400 μmol/l ). Reciprocal median latency (RML) was compared between groups. Latency was significantly slower in patients who were off-diet than in patients on-diet, on a maternal diet or in normal controls. Reaction times in both diet-treated groups were not significantly different from normal controls. In 16 women planning pregnancy we obtained values before and after they commenced the maternal diet. Stricter control of Phe levels resulted in a significant improvement in reaction times. We conclude that saccadometry is useful in monitoring PKU patients. Adult patients with PKU not on a protein-restricted diet have significantly slower reaction times than controls. In addition, off-diet patients have significantly slower reaction times than on-diet. Paired data show that effects of Phe levels on reaction time are reversible.
Literatur
Zurück zum Zitat Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414–421PubMedCrossRef
Zurück zum Zitat Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington's disease. Exp Brain Res 169:237–245PubMedCrossRef Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington's disease. Exp Brain Res 169:237–245PubMedCrossRef
Zurück zum Zitat Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–120PubMedCrossRef Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114–120PubMedCrossRef
Zurück zum Zitat Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–79PubMedCrossRef Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74–79PubMedCrossRef
Zurück zum Zitat Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62PubMedCrossRef Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59–62PubMedCrossRef
Zurück zum Zitat Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99:S22–S32PubMedCrossRef
Zurück zum Zitat Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255PubMedCrossRef Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251–255PubMedCrossRef
Zurück zum Zitat de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–89PubMedCrossRef de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86–89PubMedCrossRef
Zurück zum Zitat Gassió R, Campistol J, Vilaseca MA, Lambruschini N, Cambra FJ, Fusté E (2003) Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478PubMedCrossRef Gassió R, Campistol J, Vilaseca MA, Lambruschini N, Cambra FJ, Fusté E (2003) Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92:1474–1478PubMedCrossRef
Zurück zum Zitat Gentile JK, Ten Hoedt AE, Bosch AM (2010) Psychosocial aspects of PKU: hidden disabilities—a review. Mol Genet Metab 99(Suppl 1):S64–67PubMedCrossRef Gentile JK, Ten Hoedt AE, Bosch AM (2010) Psychosocial aspects of PKU: hidden disabilities—a review. Mol Genet Metab 99(Suppl 1):S64–67PubMedCrossRef
Zurück zum Zitat Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123PubMedCrossRef Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113–123PubMedCrossRef
Zurück zum Zitat Levy HL, Ghavami M (1996) Maternal phenylketonuria: a metabolic teratogen. Teratology 53:176–184PubMedCrossRef Levy HL, Ghavami M (1996) Maternal phenylketonuria: a metabolic teratogen. Teratology 53:176–184PubMedCrossRef
Zurück zum Zitat Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700–705PubMed
Zurück zum Zitat Ober JK, Przedpelska-Ober E, Gryncewicz W et al (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187–198 Ober JK, Przedpelska-Ober E, Gryncewicz W et al (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187–198
Zurück zum Zitat Pearson BC, Armitage KR, Horner CWM, Carpenter RHS (2007) Saccadometry: the possible application of latency distribution measurement for monitoring concussion. Br J Sports Med 41:610–612PubMedCrossRef Pearson BC, Armitage KR, Horner CWM, Carpenter RHS (2007) Saccadometry: the possible application of latency distribution measurement for monitoring concussion. Br J Sports Med 41:610–612PubMedCrossRef
Zurück zum Zitat Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413–420PubMed Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413–420PubMed
Zurück zum Zitat Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169–1178PubMedCrossRef Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169–1178PubMedCrossRef
Zurück zum Zitat Donlon J, Levy H, Scriver CR (2008) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Valle D, Beaudet AL, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, online. McGraw-Hill, New York Donlon J, Levy H, Scriver CR (2008) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Valle D, Beaudet AL, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, online. McGraw-Hill, New York
Zurück zum Zitat van Spronsen FJ, Hoeksma M, Reijngoud D (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef van Spronsen FJ, Hoeksma M, Reijngoud D (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46–51PubMedCrossRef
Zurück zum Zitat Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145–1156PubMedCrossRef
Zurück zum Zitat Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55–57PubMedCrossRef
Metadaten
Titel
Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time
verfasst von
Charlotte Dawson
Elaine Murphy
Charlé Maritz
Heidi Chan
Charlotte Ellerton
R. H. S. Carpenter
Robin H. Lachmann
Publikationsdatum
01.04.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 2/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-010-9276-2

Weitere Artikel der Ausgabe 2/2011

Journal of Inherited Metabolic Disease 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.